½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹APOBEC3D/F¶à¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • Íÿ¹APOBEC3D/F¶à¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW2294
    • Ó¦Óà : ½öÓÃÓÚ¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul/200ul/25ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·

ÖÐÎÄÃû³Æ:  Íÿ¹APOBEC3D/F¶à¿Ë¡¿¹Ìå   

Ó¢ÎÄÃû³Æ:  Anti-APOBEC3D/F rabbit polyclonal antibody

±ð       Ãû: A3D; ARP6; APOBEC3E; APOBEC3DE/A3F; KA6; ARP8; BK150C2.4.MRNA

´¢       ´æ: Àä¶³£¨-20¡æ£© ±Ü¹â

¿¹       Ô­: APOBEC3D/F

ËÞ       Ö÷: Rabbit

·´Ó¦ÖÖÊô: Human

Ïà¹ØÀà±ð: Ò»¿¹

±ê ¼Ç Îï: Unconjugate

¿Ë¡ÀàÐÍ: Unconjugate

¼¼Êõ¹æ¸ñ

Background:

DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. Exhibits antiviral activity against vif-deficient HIV-1. After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA. The resultant detrimental levels of mutations in the proviral genome, along with a deamination-independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single-or double-stranded RNA. May inhibit the mobility of LTR and non-LTR retrotransposons.

Applications:

WB, IHC

Name of antibody:

APOBEC3D/F

Immunogen:

Synthesized peptide derived from internal of human APOBEC3D/F.

Full name:

apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D/F

Synonyms£º

A3D; ARP6; APOBEC3E; APOBEC3DE/A3F; KA6; ARP8; BK150C2.4.MRNA

SwissProt:

Q96AK3/Q8IUX4

IHC positive control:

Human placenta tissue

IHC Recommend dilution:

50-100

WB Predicted band size:

47/45 kDa

WB Positive control:

MCF7 cells and COS-7cells lysates

WB Recommended dilution:

500-3000




¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿